Skip to content
Search

Latest Stories

AIMp rebrands as IPA to amplify the voice of independent pharmacies

AIMp rebrands as IPA to amplify the voice of independent pharmacies

David Vanns, currently serving as the chairman of AIMp, will retain his position as chairman of Independent Pharmacies Association (IPA) 

The Association of Independent Multiple Pharmacies (AIMp) has changed its name to the Independent Pharmacies Association (IPA).

AIMp, now IPA, stated that rebranding was prompted by the demand from independent community pharmacists for an association that properly represents their interests.


The membership of the Independent Pharmacies Association will not be restricted to pharmacy owners with multiple branches, as was the case with AIMp, but will be open to all independents, it announced today (Tuesday).

It believes that the switch will “provide a clearer identity and afford a strong voice to the thousands of independent pharmacies in England and Wales.”

Furthermore, the IPA noted that it will not primarily function as an insurance organisation with membership attached, but it will be “fighting for and representing its members across all fronts.”

David Vanns, currently serving as the chairman of AIMp, will retain his position as chairman of IPA.

Vanns said: “Our businesses are set up very differently to others in the sector. For independent brick and mortar contractors, supplying NHS prescriptions, and services and treatments via the new NHS Pharmacy First scheme, is their priority.

“IPA is truly run by pharmacy contractors for pharmacy contractors. We understand community pharmacy. Our growing membership is a testament to our organisation’s dedication to speak up with courage and conviction on behalf of independent community pharmacies and offer them the support they need.”

The association highlighted that independent pharmacies, many of which are family owned, constitute roughly 68 per cent of the sector in England, and large chains make up about 29 per cent. However, the latter are “over-represented on the board of Community Pharmacy England, the body that negotiates contracts with the Government and NHS.”

“Independent community pharmacies do not operate the same business models as the large chains (Boots, supermarkets, Superdrug etc). They are not health and beauty, sandwiches and snacks-on-the-go retailers first, supplying medicines and prescriptions second. They are not corporates. Over 90 per cent of the independent’s business derives directly from the NHS,” the IPA said.

Despite the crucial frontline healthcare they provide, independent pharmacies in the country “struggle to make themselves heard and their needs are often overlooked,” the IPA stated adding that its strategy is to “ensure our members can thrive and are fully supported and represented.”

Vanns added: “We will press the cause of all independents and ensure they are properly represented on CPE and to the external stakeholders and decision-makers.

“We are here for our customers, our patients, and we’re always happy to work closely with the NHS to relieve pressure in other areas, but it is only right that we are treated with respect and that we are paid accordingly. From now on, the IPA will be making certain that is the case.”

'We need unity and not split the voice'

Commenting on AIMp's transition into IPA, Paul Rees, CEO of the National Pharmacy Association (NPA) said: “At a time when pharmacies are under such intense pressure, they need us to focus on the fight against the broken contract and unfair funding, which is damaging so many."

“We need unity in the sector and not split the voice of independent pharmacies when we need to concentrate on winning better funding and ending the closures. That’s our focus at the NPA."

Expanding on the NPA's priorities, he said: “As the largest membership body for community pharmacies, we’re proud to support the majority of independents across the UK. Our focus is entirely on making a powerful case for pharmacies, in public, with government and opposition and with the NHS.

“We will work with all our colleagues within our sector – anytime, anywhere – in the interests of unity to end pharmacy closures and end the misery of unfair and inadequate funding.”

More For You

NICE approves AstraZeneca’s twice-a-day tablet ‘capivasertib’ for advanced breast cancer

HR-positive, HER2-negative advanced breast cancer is currently incurable, and treatment aims to slow progression and prolong life

Gettyimages

NICE approves twice-a-day tablet for advanced breast cancer

Every year, thousands of people with hormone receptor (HR)-positive HER2-negative breast cancer could benefit from a new twice-a-day tablet, now set to be funded immediately through the Cancer Drugs Fund.

The National Institute for Health and Care Excellence (NICE) has approved the use of capivasertib (also known as Truqap), in combination with fulvestrant, as an option for around 1,100 adults with HR-positive HER2-negative breast cancer that has certain genetic mutations and has spread.

Keep ReadingShow less
ABPI and government fast-track VPAG scheme review to address high medicine payment rates

The 2025 VPAG payment rate for newer medicines has been set at 22.9 per cent.

Photo credit: gettyimages

Review of 2024 VPAG scheme to be completed by June

The Association of the British Pharmaceutical Industry (ABPI) and the government have agreed to bring forward a planned review of the 2024 Voluntary Scheme for Branded Medicines Pricing, Access, and Growth (VPAG), originally scheduled for autumn 2025.

The review is expected to be completed in June 2025, aligning with the anticipated release of the government’s 10-year NHS Plan and the Life Sciences Sector Plan as part of the broader industry strategy this summer.

Keep ReadingShow less
AAH upgrades ordering portal, making procurement easier for pharmacies

AAH Cascade compares prices and availability across suppliers

AAH Warehouse

AAH upgrades ordering portal to improve product visibility

Leading pharmaceutical wholesaler AAH Pharmaceuticals Ltd has introduced new digital functionalities to AAH Cascade, its independently managed ordering portal, making procurement easier and more cost-effective for pharmacies.

AAH Cascade compares product prices and availability across multiple suppliers, eliminating the need for manual searches.

Keep ReadingShow less
Majority of Brits neglect consistent skincare routine,  survey finds

On average, Brits go to bed without washing their face twice a week.

Photo credit: gettyimages

Skincare: One in five Brits go to bed without washing their face daily, survey finds

Nearly two-thirds of Brits (60 per cent) neglect a consistent skincare routine,with almost one in five going to bed without washing their face daily, according to a new survey by consumer health company Kenvue.

The UK-wide survey of 2,000 people revealed that one-third of respondents (34 per cent) spend five minutes or less on their daily skincare routine. On average, Brits go to bed without washing their face twice a week.

Keep ReadingShow less
Risk of pharmacy closures remains despite record funding uplift

Community pharmacy sector remains in a fragile position as the funding gap is still significant, says CCA.

gettyimages

Pharmacy closures still a risk as funding deal fails to cover costs – warns CCA

The community pharmacy sector has secured the largest funding uplift across the NHS, yet concerns remain that it may not be enough to prevent further closures and service reductions.

Following a six-week consultation with Community Pharmacy England (CPE), the government has approved a £3.073 billion funding package for 2025/26, supplemented by an additional £215 million to support Pharmacy First and other Primary Care Recovery Plan services.

Keep ReadingShow less